spotsaas-logo
Get Listed

Compare Phreesia vs NextPatient vs Solutionreach

Phreesia
Get Quote
Get Quote
NextPatient
Get Quote
Get Quote
Solutionreach
Get Quote
Get Quote

Overview

Description

Revolutionize the patient intake process with Phreesia, a cutting-edge Health System Patient Intake Software. Designed to address the complex challenges faced by health systems and patients ... Read More

NextPatient, the cutting-edge solution for modern medical practices, revolutionizes the patient experience by integrating innovative technology. As the go-to technology ally for online ... Read More

Introducing Solutionreach – The Ultimate Patient Engagement Solution designed to revolutionize the way you connect with your patients. Say goodbye to the time-consuming tasks of patient ... Read More

Free Trial Availability
  • No free trial
  • No free trial
  • No free trial
User Ratings
Get Quote
Get Quote
Get Quote

Software Demo

Demo

Pricing

Pricing Option
        Pricing Plans
        • Not Available
        • Not Available
        • Not Available

        Other Details

        Organization Types supported
        • Small Business
        • Large Enterprises
        • Medium Business
        • Freelancers
        • Individuals
        • Small Business
        • Large Enterprises
        • Medium Business
        • Freelancers
        • Individuals
        • Small Business
        • Large Enterprises
        • Medium Business
        • Freelancers
        • Individuals
        Platforms Supported
        • Mobile - iOS
        • Mobile - Android
        • Browser Based (Cloud)
        • Browser Based (Cloud)
        • Mobile - iOS
        • Mobile - Android
        • Browser Based (Cloud)
        • Browser Based (Cloud)
        • Mobile - iOS
        • Mobile - Android
        • Browser Based (Cloud)
        • Browser Based (Cloud)
        Modes of support
        • 24/7 (Live rep)
        • Business Hours
        • Online
        • 24/7 (Live rep)
        • Business Hours
        • Online
        • 24/7 (Live rep)
        • Business Hours
        • Online
        API Support
        • Not Available
        • Available
        • Not Available
        Get Quote
        Get Quote
        Get Quote

        User Reviews

        User Ratings

        4

        (based on 18 reviews)

        No reviews available for the product

        4.4

        (based on 135 reviews)

        Rating Distribution

        Excellent

        0

        Very Good

        0

        Good

        0

        Poor

        0

        Terible

        0

        No reviews available for the product

        Excellent

        0

        Very Good

        0

        Good

        0

        Poor

        0

        Terible

        0

        Customers

        Customers
        Piedmont

        Piedmont

        VCS

        VCS

        Houston

        Houston

        No Customers information available.

        No Customers information available.

        Media and Screenshots

        Screenshots
        Custom Report

        1 Screenshots

        No screenshots available.

        No screenshots available.

        Videos
        video-0

        1 Videos

        video-0

        2 Videos

        video-0

        2 Videos

        Add to Compare

        Compare similar softwares

        No Alternative Products ☹️

        Frequently Asked Questions (FAQs)

        Stuck on something? We're here to help with all the questions and answers in one place.

        Neither Phreesia nor NextPatient offers a free trial.

        Phreesia is designed for Large Enterprises, Small Business and Medium Business.

        NextPatient is designed for Large Enterprises, Small Business and Medium Business.

        Pricing details for both Phreesia and NextPatient are unavailable at this time. Contact the respective providers for more information.

        Some top alternatives to Phreesia includes and undefined.

        Some top alternatives to NextPatient includes and undefined.

        Disclaimer: This research has been collated from a variety of authoritative sources. We welcome your feedback at [email protected].